Literature DB >> 11517216

High affinity binding of brain myosin-Va to F-actin induced by calcium in the presence of ATP.

S B Tauhata1, D V dos Santos, E W Taylor, M S Mooseker, R E Larson.   

Abstract

Brain myosin-Va consists of two heavy chains, each containing a neck domain with six tandem IQ motifs that bind four to five calmodulins and one to two essential light chains. Previous studies demonstrated that myosin-Va exhibits an unusually high affinity for F-actin in the presence of ATP and that its MgATPase activity is stimulated by micromolar Ca(2+) in a highly cooperative manner. We demonstrate here that Ca(2+) also induces myosin-Va binding to and cosedimentation with F-actin in the presence of ATP in a similar cooperative manner and calcium concentration range as that observed for the ATPase activity. Neither hydrolysis of ATP nor buildup of ADP was required for Ca(2+)-induced cosedimentation. The Ca(2+)-induced binding was inhibited by low temperature or by 0.6 m NaCl, but not by 1% Triton X-100. Tight binding between myosin-Va and pyrene-labeled F-actin in the presence of ATP and Ca(2+) was also detected by quenching of the pyrene fluorescence. Negatively stained preparations of actomyosin-Va under Ca(2+)-induced binding conditions showed tightly packed F-actin bundles cross-linked by myosin-Va. Our data demonstrate that high affinity binding of myosin-Va and F-actin in the presence of ATP or 5'-O-(thiotriphosphate) is induced by micromolar concentrations of Ca(2+). Since Ca(2+) regulates both the actin binding properties and actin-activated ATPase of myosin-Va over the same concentration range, we suggest that the calcium signal may regulate the mechanism of processivity of myosin Va.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11517216     DOI: 10.1074/jbc.M102583200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Citrullination of myofilament proteins in heart failure.

Authors:  Justyna Fert-Bober; John T Giles; Ronald J Holewinski; Jonathan A Kirk; Helge Uhrigshardt; Erin L Crowgey; Felipe Andrade; Clifton O Bingham; Jin Kyun Park; Marc K Halushka; David A Kass; Joan M Bathon; Jennifer E Van Eyk
Journal:  Cardiovasc Res       Date:  2015-06-25       Impact factor: 10.787

2.  Myosin-Va binds to and mechanochemically couples microtubules to actin filaments.

Authors:  Tracy T Cao; Wakam Chang; Sarah E Masters; Mark S Mooseker
Journal:  Mol Biol Cell       Date:  2003-10-17       Impact factor: 4.138

3.  Methods for identifying and averaging variable molecular conformations in tomograms of actively contracting insect flight muscle.

Authors:  Shenping Wu; Jun Liu; Mary C Reedy; Hanspeter Winkler; Michael K Reedy; Kenneth A Taylor
Journal:  J Struct Biol       Date:  2009-08-19       Impact factor: 2.867

4.  Impacts of Usher syndrome type IB mutations on human myosin VIIa motor function.

Authors:  Shinya Watanabe; Nobuhisa Umeki; Reiko Ikebe; Mitsuo Ikebe
Journal:  Biochemistry       Date:  2008-08-13       Impact factor: 3.162

5.  Control of granule mobility and exocytosis by Ca2+ -dependent formation of F-actin in pancreatic duct epithelial cells.

Authors:  Seung-Ryoung Jung; Mean-Hwan Kim; Bertil Hille; Duk-Su Koh
Journal:  Traffic       Date:  2009-01-24       Impact factor: 6.215

6.  BMP-2 overexpression augments vascular smooth muscle cell motility by upregulating myosin Va via Erk signaling.

Authors:  Ming Zhang; Min Yang; Li-ping Liu; Wayne Bond Lau; Hai Gao; Man-kun Xin; Li-Xiao Su; Jian Wang; Shu-Juan Cheng; Qian Fan; Jing-Hua Liu
Journal:  Oxid Med Cell Longev       Date:  2014-03-20       Impact factor: 6.543

7.  Control of mitochondrial motility and distribution by the calcium signal: a homeostatic circuit.

Authors:  Muqing Yi; David Weaver; György Hajnóczky
Journal:  J Cell Biol       Date:  2004-11-15       Impact factor: 10.539

8.  Myosin V: regulation by calcium, calmodulin, and the tail domain.

Authors:  Dimitry N Krementsov; Elena B Krementsova; Kathleen M Trybus
Journal:  J Cell Biol       Date:  2004-03-08       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.